Investigation of a tetrahydroisoquinoline scaffold as dual-action steroid sulfatase inhibitors generated by parallel solid-phase synthesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigation of a tetrahydroisoquinoline scaffold as dual-action steroid sulfatase inhibitors generated by parallel solid-phase synthesis

Published:2013 Issue:4 Volume:4 Page:681
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Ouellet Étienne,Maltais René,Ouellet Charles,Poirier Donald

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2013/MD/C3MD20354A

Reference40 articles.

1. Human sulfatases: A structural perspective to catalysis

2. Endogenous Hormones and Breast Cancer Risk

3. The development of steroid sulphatase inhibitors

4. Sulfatases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents;Bioorganic & Medicinal Chemistry;2024-03

2. Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis;Journal of Medicinal Chemistry;2022-08-22

3. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design;Expert Opinion on Drug Discovery;2021-04-28

4. Recent Studies on Aromatase and Sulfatase Involved in Breast Cancer and their Inhibitors;Current Enzyme Inhibition;2020-05-04

5. Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer;Bioorganic Chemistry;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3